Core Viewpoint - Estée Lauder's "Reimagining Beauty" transformation strategy has shown positive results after one year, with significant improvements in sales and profitability in the second quarter of fiscal year 2026 [1][3] Financial Performance - In Q2 of fiscal year 2026, Estée Lauder achieved net sales of $4.2 billion, a 6% year-over-year increase, with organic net sales growing by 4% [1] - The company reported a net profit of $162 million, recovering from losses in the previous year [1] - For the first half of fiscal year 2026, net sales increased by 5% to $7.71 billion, with net profit turning from a loss of $746 million to a profit of $209 million [1] Market Performance - The growth in the Chinese mainland market was particularly notable, with organic net sales increasing by 13% in Q2, marking the second consecutive quarter of double-digit growth [3] - Estée Lauder's performance in the high-end beauty market in China outpaced the overall industry, with market share growth across all categories and channels [3] Strategic Insights - The growth is attributed to the "Profit Recovery and Growth Plan" (PRGP) and effective execution of product innovation and marketing strategies, including the "Double 11" shopping festival [3] - The company's dual strategy of "high-end consolidation and young consumer engagement" has effectively captured both mature and younger consumer segments, enhancing its competitive advantage [4] Future Outlook - Based on strong performance, Estée Lauder has raised its full-year fiscal 2026 outlook, expecting organic net sales growth of 1% to 3% and adjusted operating margin between 9.8% and 10.2% [4] - The company anticipates challenges in the second half of the year but remains optimistic about restoring organic sales growth and achieving operating margin expansion for the first time in four years [5]

Core Viewpoint - Estée Lauder is considering selling its Korean beauty brand, Dr. Jart+, amid declining performance and increasing market competition, reflecting a strategic shift towards more promising brands [1][4]. Group 1: Brand Performance and Market Context - Dr. Jart+ was established in 2004 and gained popularity with its "post-medical" positioning, expanding internationally with significant sales growth, particularly in the U.S. and China [3][4]. - After Estée Lauder acquired a one-third stake in Dr. Jart+'s parent company, Have & Be, in 2015, the brand's sales surged from 863 billion KRW to 4.898 trillion KRW by 2018, marking over a fivefold increase [4]. - However, Dr. Jart+'s growth has not sustained, with projected revenues for 2025 at approximately $150 million, significantly below the initial target of $500 million [4]. Group 2: Financial Performance of Estée Lauder - Estée Lauder's financial reports indicate a troubling trend, with net sales for fiscal year 2025 dropping to $14.326 billion, an 8% decline, and a net loss of $1.133 billion, a stark contrast to the previous year's profit of $390 million [6]. - The company's various business segments, including skincare and makeup, have experienced revenue declines, with makeup sales down 6% and operating profits in the color cosmetics and fragrance sectors turning negative [6][8]. Group 3: Strategic Shifts and Future Directions - Estée Lauder's new CEO, Stéphane de La Faverie, has initiated a significant transformation strategy called "Beauty Reimagined," focusing on consumer-centric growth and prioritizing investment in high-potential brands [7][10]. - The company is actively evaluating its brand portfolio, with several brands, including Too Faced and Smashbox, potentially on the chopping block due to underperformance [8]. - The strategic shift aims to concentrate resources on luxury and high-growth brands, with over 70% of revenue coming from high-end beauty products like La Mer, while also exploring opportunities in the anti-aging and efficacy-driven segments [10][11].

Core Insights - Estée Lauder Companies reported a 3% organic sales growth in Q1 of fiscal year 2026, a significant recovery compared to a 13% decline in the previous quarter [1] - The company's net sales increased by 4% to $3.5 billion, with organic net sales also growing by 3% [1] - Gross margin improved by 100 basis points from 72.4% to 73.4%, driven by profit recovery and efficiency improvements [1] Financial Performance - Operating margin reached 4.9%, a notable improvement from -3.6% in the same period last year [1] - Adjusted operating margin increased by 300 basis points from 4.3% to 7.3%, attributed to profit recovery and growth initiatives [1] Market Performance - The Asia-Pacific region achieved a 9% organic net sales growth, driven by strong performance in the fragrance category and inventory optimization [2] - The mainland China market saw a 9% increase, with all categories gaining market share, particularly brands like La Mer, Le Labo, and Tom Ford [2] - Growth in mainland China was supported by innovative products and targeted marketing activities that enhanced online sales [2] Strategic Outlook - Fiscal year 2026 is positioned as a transformative year for the company, with an outlook of organic net sales growth expected to be flat to 3% [2] - Adjusted operating margin is projected to be between 9.4% and 9.9% for the full fiscal year [2] - The CEO emphasized the positive momentum from operational changes and the company's confidence in achieving its fiscal year 2026 outlook [2]